IP Library Granted Patent US 10,300,180
Granted Patent B1
US 10,300,180 · App. 15/730,421 · Granted May 28, 2019

Wound care and infusion method and system utilizing a therapeutic agent

Inventors: Tony Quisenberry (Highland Village, TX); Sam K. McSpadden (Austin, TX); Niran Balachandran (Lewisville, TX); Robert K. Lasalle (Gainesville, TX); Thomas C. Anderson (Frisco, TX); Kathryn Davis (Trophy Club, TX)
Assignee: ThermoTek, Inc.
A61M1/0084A61M1/0092A61M35/00A61N5/0624A61M39/24A61M2202/0208A61M2205/3337A61M2205/3344A61M2205/3592A61M2205/3673A61M2205/75A61N2005/0651A61N2005/0661
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,300,180
App. No.
15/730,421
Filed
Oct 11, 2017
Granted
May 28, 2019
Kind
B1
Examiner
WENG, KAI H
Art Unit
3781
USPC
604/543
Abstract

A wound-care system includes a first pump fluidly coupled to an oxygen source. An oxygen concentrator is fluidly coupled to the first pump. A humidification system is fluidly coupled to the oxygen concentrator. A wound dressing is fluidly coupled to the humidification system and to an exudate chamber. A negative-pressure tube fluidly is coupled to the exudate chamber. A first valve is disposed between the first pump and the oxygen concentrator. A second valve is disposed between the oxygen concentrator and the wound dressing. A third valve is disposed in the negative-pressure tube. Selective activation of the first pump, the first valve, the second valve, and the third valve facilitates delivery of at least one of individual, sequential, or simultaneous negative-pressure treatment and oxygen-rich fluid treatment to the wound via the wound dressing.

Claims (43)

1. A wound-care system comprising:

a first pump fluidly coupled to an oxygen source;

an oxygen concentrator fluidly coupled to the first pump;

a humidification system fluidly coupled to the oxygen concentrator;

a wound dressing fluidly coupled to the humidification system and to an exudate chamber;

a negative-pressure tube fluidly coupled to the exudate chamber;

a first pressure sensor exposed to pressure in the negative-pressure tube;

a second pressure sensor exposed to pressure between the oxygen concentrator and the wound dressing;

a first valve disposed between the first pump and the oxygen concentrator, the first valve being operable to selectively direct flow of fluid from the first pump to at least one of the oxygen concentrator and the humidification system;

a second valve disposed between the oxygen concentrator and the wound dressing, the second valve being operable to selectively vent the wound dressing to an exterior environment;

a third valve disposed in the negative-pressure tube, the third valve being operable to selectively vent the wound dressing to the exterior environment; and

wherein selective activation of the first pump, the first valve, the second valve, and the third valve facilitates delivery of at least one of individual, sequential, or simultaneous negative-pressure treatment and oxygen-rich fluid treatment to the wound via the wound dressing.

2. The wound-care system of claim 1 , wherein:

the negative-pressure tube is fluidly coupled to an inlet of the first pump; and

a fourth valve is disposed in the negative-pressure tube.

3. The wound-care system of claim 1 , comprising:

a second pump fluidly coupled to the negative-pressure tube; and

wherein selective activation of the first pump and the second pump facilitates delivery of at least one of individual, sequential, or simultaneous oxygen-rich fluid treatment and negative-pressure treatment.

4. The wound-care system of claim 3 , wherein the second pump configured to apply negative pressure to a wound via the wound dressing.

5. The wound-care system of claim 3 , wherein the first pump and the second pump are operated independently of each other.

6. The wound-care system of claim 1 , wherein:

the humidification system comprises a proton-exchange tube;

oxygen-rich fluid is circulated through the proton-exchange tube; and

an exterior of the proton-exchange tube is exposed to ambient fluid.

7. The wound-care system of claim 1 , wherein the humidification system comprises a channel disposed in a disposable container, the channel containing sterile water through which oxygen-rich fluid discharged from the oxygen concentrator.

8. The wound-care system of claim 1 , wherein the oxygen concentrator is a pressure-swing adsorption device.

9. The wound-care system of claim 1 , further comprising a disposable canister arranged upstream of the wound dressing.

10. A wound-care system comprising:

a first pump fluidly coupled to an oxygen source;

a humidification system fluidly coupled to the first pump; and

a wound dressing fluidly coupled to the humidification system and to an exudate chamber;

a negative-pressure tube fluidly coupled to the exudate chamber;

a first pressure sensor exposed to pressure in the negative-pressure tube;

a second pressure sensor exposed to pressure between the first pump and the wound dressing;

a first valve disposed between the first pump and the humidification system, the first valve being operable to selectively direct flow of fluid from the first pump to the humidification system; a second valve disposed between the first pump and the wound dressing, the second valve being operable to selectively vent the wound dressing to an exterior environment; a third valve disposed in the negative-pressure tube, the third valve being operable to selectively vent the wound dressing to the exterior environment; and

wherein selective activation of the first pump, the first valve, and the second valve, facilitates delivery of at least one of individual, sequential, or simultaneous negative-pressure treatment and oxygen-rich fluid treatment to the wound via the wound dressing.

11. The wound-care system of claim 10 , wherein:

the negative-pressure tube is fluidly coupled to an inlet of the first pump; and

a fourth valve is disposed in the negative-pressure tube.

12. The wound-care system of claim 10 , comprising:

a second pump fluidly coupled to the negative-pressure tube; and

wherein selective activation of the first pump and the second pump facilitates delivery of at least one of individual, sequential, or simultaneous oxygen-rich fluid treatment and negative-pressure treatment to the wound via the wound dressing.

13. The wound-care system of claim 10 , wherein the oxygen source is an oxygen concentrator.

Assignments (3)
SECURITY AGREEMENT Recorded Nov 12, 2020
From: THERMOTEK, INC.
To: OXFORD FINANCE LLC, AS AGENT
Reel/Frame 054401/0337 →
SECURITY AGREEMENT Recorded Oct 22, 2020
From: THERMOTEK, INC.
To: OXFORD FINANCE LLC, AS AGENT
Reel/Frame 054214/0105 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2017
From: QUISENBERRY, TONY; MCSPADDEN, SAM K.; BALACHANDRAN, NIRAN; LASALLE, ROBERT K.; ANDERSON, THOMAS C.; DAVIS, KATHRYN
To: THERMOTEK, INC.
Reel/Frame 044014/0369 →
Continuity (2)
Continuation In Part 14197324 · Mar 5, 2014
Provisional Application 61776328 · Mar 11, 2013
Cited By (4)
US 12,420,006 US 12,447,059 US 12,447,093 US 12,636,200